[{"address1": "7800 Susquehanna St.", "address2": "Suite 505", "city": "Pittsburgh", "state": "PA", "zip": "15208", "country": "United States", "phone": "412 894 1853", "website": "https://lipella.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jonathan  Kaufman M.B.A., Ph.D.", "age": 59, "title": "Co-Founder, Chairman, CEO, President, Secretary & Treasurer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 233300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas  Johnston CPA", "age": 40, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 165000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michele  Gruber", "title": "Director of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Janet  Okonski", "title": "Director of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Katie  Johnston", "title": "Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.171, "open": 0.2299, "dayLow": 0.2299, "dayHigh": 0.23, "regularMarketPreviousClose": 0.171, "regularMarketOpen": 0.2299, "regularMarketDayLow": 0.2299, "regularMarketDayHigh": 0.23, "payoutRatio": 0.0, "beta": 0.143, "forwardPE": -0.071875, "volume": 15850, "regularMarketVolume": 15850, "averageVolume": 10562, "averageVolume10days": 2790, "averageDailyVolume10Day": 2790, "bid": 0.187, "ask": 0.3225, "bidSize": 20831, "askSize": 5500, "marketCap": 1062792, "fiftyTwoWeekLow": 0.165, "fiftyTwoWeekHigh": 7.31, "allTimeHigh": 61.76, "allTimeLow": 0.165, "priceToSalesTrailing12Months": 2.7266247, "fiftyDayAverage": 0.25094, "twoHundredDayAverage": 0.991555, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -259499, "profitMargins": 0.0, "floatShares": 4329355, "sharesOutstanding": 4620837, "sharesShort": 100093, "sharesShortPriorMonth": 133447, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.0224, "heldPercentInsiders": 0.06308, "heldPercentInstitutions": 0.013049999, "shortRatio": 3.32, "shortPercentOfFloat": 0.0235, "impliedSharesOutstanding": 4620837, "bookValue": 0.322, "priceToBook": 0.71428573, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -5329759, "trailingEps": -3.81, "forwardEps": -3.2, "lastSplitFactor": "1:8", "lastSplitDate": 1731024000, "enterpriseToRevenue": -0.666, "enterpriseToEbitda": 0.048, "52WeekChange": -0.8945055, "SandP52WeekChange": 0.1575526, "quoteType": "EQUITY", "currentPrice": 0.23, "recommendationKey": "none", "totalCash": 1855771, "totalCashPerShare": 0.402, "ebitda": -5407074, "totalDebt": 264083, "quickRatio": 2.889, "currentRatio": 3.237, "totalRevenue": 389783, "debtToEquity": 17.752, "revenuePerShare": 0.128, "returnOnAssets": -1.49946, "returnOnEquity": -3.61767, "grossProfits": -3178582, "freeCashflow": -2827184, "operatingCashflow": -4775734, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -13.879411, "financialCurrency": "USD", "symbol": "LIPO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "marketState": "CLOSED", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1671460200000, "regularMarketChange": 0.059, "regularMarketDayRange": "0.2299 - 0.23", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 10562, "fiftyTwoWeekLowChange": 0.065, "exchange": "PNK", "messageBoardId": "finmb_35907207", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 34.502922, "regularMarketPrice": 0.23, "shortName": "Lipella Pharmaceuticals Inc.", "longName": "Lipella Pharmaceuticals Inc.", "corporateActions": [], "regularMarketTime": 1769793934, "fiftyTwoWeekLowChangePercent": 0.39393938, "fiftyTwoWeekRange": "0.165 - 7.31", "fiftyTwoWeekHighChange": -7.08, "fiftyTwoWeekHighChangePercent": -0.96853626, "fiftyTwoWeekChangePercent": -89.45055, "epsTrailingTwelveMonths": -3.81, "epsForward": -3.2, "fiftyDayAverageChange": -0.02093999, "fiftyDayAverageChangePercent": -0.083446205, "twoHundredDayAverageChange": -0.76155496, "twoHundredDayAverageChangePercent": -0.7680411, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-12-20", "cryptoTradeable": false, "displayName": "Lipella Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-01-31"}]